Smoking and the risk of diabetic nephropathy in patients with type 1 and type 2 diabetes: A meta-analysis of observational studies

Oncotarget

Volumn 8, Issue 54, 2017, Pages 93209-93218

  Jiang, Ning ^a   Huang, Feng ^b   Zhang, Xiurong ^a  

^a Shandong Province Maternal and Child Health Care Hospital   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Cigarette smoking; Diabetic nephropathy; End stage renal disease; Macroalbuminuria; Microalbuminuria

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; END STAGE RENAL DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; META ANALYSIS (TOPIC); MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW;

EID: 85032680022     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.21478     Document Type: Article

References (52)

1. Zhang W, Yang Z, Li X, Wen J, Zhang H, Wang S, Wang X, Zhou H, Fang W, Qin L, Su Q. The functional Q84R polymorphism of TRIB3 gene is associated with diabetic nephropathy in Chinese type 2 diabetic patients. Gene. 2015; 555:357-61
2. Ahn JH, Yu JH, Ko SH, Kwon HS, Kim DJ, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Han K, Cha BY, et al. Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. Diabetes Metab J. 2014; 38:109-19
3. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005; 28:164-76
4. Narres M, Claessen H, Droste S, Kvitkina T, Koch M, Kuss O, Icks A. The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review. PLoS One. 2016; 11:e0147329
5. Yeom H, Lee JH, Kim HC, Suh I. The Association Between Smoking Tobacco After a Diagnosis of Diabetes and the Prevalence of Diabetic Nephropathy in the Korean Male Population. J Prev Med Public Health. 2016; 49:108-17
6. Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig. 2017; 8:6-18
7. Xue R, Gui D, Zheng L, Zhai R, Wang F, Wang N. Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. J Diabetes Res. 2017; 2017:1839809
8. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367:1747-57
9. Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, He L, Su X. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017; 32:475-87
10. Feodoroff M, Harjutsalo V, Forsblom C, Thorn L, Waden J, Tolonen N, Lithovius R, Groop PH. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes. Acta Diabetol. 2016; 53:525-33
11. Zitt E, Pscheidt C, Concin H, Kramar R, Lhotta K, Nagel G. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria. PLoS One. 2016; 11:e0161376
12. Yu MK, Weiss NS, Ding X, Katon WJ, Zhou XH, Young BA. Associations between depressive symptoms and incident ESRD in a diabetic cohort. Clin J Am Soc Nephrol. 2014; 9:920-8
13. Furukawa S, Yamamoto S, Todo Y, Maruyama K, Miyake T, Ueda T, Niiya T, Senba T, Torisu M, Kumagi T, Miyauchi S, Sakai T, Minami H, et al. Association between subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus. Endocr J. 2014; 61:1011-8
14. Okada K, Osuga J, Kotani K, Yagyu H, Miyamoto M, Nagasaka S, Ishibashi S. Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional study. Tob Induc Dis. 2012; 10:12
15. Wolf G, Busch M, Muller N, Muller UA. Association between socioeconomic status and renal function in a population of German patients with diabetic nephropathy treated at a tertiary centre. Nephrol Dial Transplant. 2011; 26:4017-23
16. Hsu CC, Hwang SJ, Tai TY, Chen T, Huang MC, Shin SJ, Wen CP, Shih YT, Yang HJ, Chang CT, Chang CJ, Loh CH, Fuh MT, et al. Cigarette smoking and proteinuria in Taiwanese men with Type 2 diabetes mellitus. Diabet Med. 2010; 27:295-302
17. Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009; 19:580-6
18. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006; 69:2057-63
19. Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F, Campos MM, Moreno A, Garcia-Hernandez A, Castro E, Garcia-Doncel LG, Serraclara A, Sanchez-Malo C, Escobar-Jimenez F. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus? Nephron Clin Pract. 2005; 101:c116-21
20. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract. 2005; 67:258-66
21. Tam TK, Cheng LP, Lau DM, Lai TC, Lai WY, Ng KK, Ng MY, Kong CW, Tsang LC. The prevalence of microalbuminuria among patients with type II diabetes mellitus in a primary care setting: cross-sectional study. Hong Kong Med J. 2004; 10:307-11
22. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care. 2002; 25:859-64
23. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes. 2001; 50:2842-9
24. Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in Type 1 diabetes mellitus. Diabet Med. 2000; 17:782-91
25. Yokoyama H, Okudaira M, Otani T, Watanabe C, Takaike H, Miuira J, Yamada H, Mutou K, Satou A, Uchigata Y, Iwamoto Y. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care. 1998; 21:1080-5
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283:2008-12
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-88
28. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Ten-year incidence of gross proteinuria in people with diabetes. Diabetes. 1995; 44:916-23
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557-60
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088-101
31. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-34
32. Barua RS, Ambrose JA. Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol. 2013; 33:1460-7
33. Caimi G, Hopps E, Montana M, Carollo C, Calandrino V, Incalcaterra E, Canino B, Lo Presti R. Nitric oxide metabolites (nitrite and nitrate) in several clinical condition. Clin Hemorheol Microcirc. 2014; 56:359-69
34. Salvatore SP, Troxell ML, Hecox D, Sperling KR, Seshan SV. Smoking-related glomerulopathy: expanding the morphologic spectrum. Am J Nephrol. 2015; 41:66-72
35. Baggio B, Budakovic A, Dalla Vestra M, Saller A, Bruseghin M, Fioretto P. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol. 2002; 13:2730-6
36. Hua P, Feng W, Ji S, Raij L, Jaimes EA. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol. 2010; 299:F732-9
37. Jaimes EA, Tian RX, Raij L. Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol. 2007; 292:H76-82
38. Tolonen N, Forsblom C, Thorn L, Waden J, Rosengard-Barlund M, Saraheimo M, Feodoroff M, Makinen VP, Gordin D, Taskinen MR, Groop PH. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia. 2009; 52:2522-30
39. Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutierrez OM, Safford M, Powe NR, McClellan WM, Investigators R. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013; 37:135-43
40. Gulliford MC. Low rates of detection and treatment of hypertension among current cigarette smokers. J Hum Hypertens. 2001; 15:771-3
41. John U, Meyer C, Hanke M, Volzke H, Schumann A. Relation between awareness of circulatory disorders and smoking in a general population health examination. BMC Public Health. 2006; 6:48
42. Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, et al. Cigarette smoking and progression of IgA nephropathy. Am J Kidney Dis. 2010; 56:313-24
43. Yamaguchi M, Ando M, Yamamoto R, Akiyama S, Kato S, Katsuno T, Kosugi T, Sato W, Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, et al. Smoking is a risk factor for the progression of idiopathic membranous nephropathy. PLoS One. 2014; 9:e100835
44. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004; 328:1105
45. Hovind P, Rossing P, Tarnow L, Parving HH. Smoking and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2003; 26:911-6
46. Orth SR, Schroeder T, Ritz E, Ferrari P. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant. 2005; 20:2414-9
47. Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci. 2004; 327:57-67
48. Phisitkul K, Hegazy K, Chuahirun T, Hudson C, Simoni J, Rajab H, Wesson DE. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci. 2008; 335:284-91
49. Haug S, Schaub MP, Salis Gross C, John U, Meyer C. Predictors of hazardous drinking, tobacco smoking and physical inactivity in vocational school students. BMC Public Health. 2013; 13:475
50. Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J, Gao P, Gerstein H, Yusuf S, Oberbauer R, Mann JF, Investigators O. Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney Int. 2015; 87:784-91
51. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007; 132:2087-102
52. Pofi R, Di Mario F, Gigante A, Rosato E, Isidori AM, Amoroso A, Cianci R, Barbano B. Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies. Curr Drug Metab. 2016; 17:497-502